Orakl Oncology's mission is to disrupt cancer drug development with a first-in-class AI-native predictive platform
Orakl Oncology's mission is to disrupt cancer drug development with a first-in-class AI-native predictive platform. By combining patient-derived biology, advanced AI, and real-world data, Orakl uncovers new drug targets, predicts patient responses, and accelerates the path from discovery to clinical success.